Investing.com - Illumina reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Illumina announced earnings per share of $1.07 on revenue of $1.22B. Analysts polled by Investing.com anticipated EPS of $0.8972 on revenue of $1.22B.
Illumina shares are up 38.94% from the beginning of the year and are trading at $298.48 , down-from-52-week-high.They are outperforming the S&P 500 which is down 12.99% from the start of the year.
Illumina shares gained 2.32% in after-hours trade the report.
Illumina follows other major Healthcare sector earnings this month
Illumina's report follows an earnings beat by J&J on April 19, who reported EPS of $2.67 on revenue of $23.43B, compared to forecasts EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on April 14 with first quarter EPS of $5.49 on revenue of $80.15B, compared to forecast for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar